ICYMI: INO-3107 for RRP Earns EC Orphan Drug Designation
Photo by Robina Weermeijer on Unsplash

ICYMI: INO-3107 for RRP Earns EC Orphan Drug Designation

  In May 2023, Pharmaceutical Technology reported that INO-3107, a DNA medicine vaccine candidate developed by biotechnology company Inovio Pharmaceuticals (“Inovio”), received Orphan Drug designation from the European Commission. INO-3107…

Continue Reading ICYMI: INO-3107 for RRP Earns EC Orphan Drug Designation